44 results on '"Bharatham, Nagakumar"'
Search Results
2. Identification of key amino acid residues in OqxB mediated efflux of fluoroquinolones using site-directed mutagenesis
3. Role of Cel5H protein surface amino acids in binding with clay minerals and measurements of its forces
4. Structure and function relationship of OqxB efflux pump from Klebsiella pneumoniae
5. The role of ZA channel water-mediated interactions in the design of bromodomain-selective BET inhibitors
6. PtdIns(3)P-bound UVRAG coordinates Golgi-ER retrograde and Atg9 transport by differential interactions with the ER tether and the beclin 1 complex.
7. Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors
8. Performance of a docking/molecular dynamics protocol for virtual screening of nutlin-class inhibitors of Mdmx
9. Monitoring Ligand-Induced Protein Ordering in Drug Discovery
10. Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer
11. Supplementary Data from Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer
12. Author Correction: BWC0977, a broad-spectrum antibacterial clinical candidate to treat multidrug resistant infections.
13. A strategy to identify a ketoreductase that preferentially synthesizes pharmaceutically relevant (S)-alcohols using whole-cell biotransformation
14. Macro Histone H2A1.2 (MacroH2A1) Protein Suppresses Mitotic Kinase VRK1 during Interphase
15. Analysis of the Active-Site Mechanism of Tyrosyl-DNA Phosphodiesterase I: A Member of the Phospholipase D Superfamily
16. NMR Solution Structure of Human Vaccinia-related Kinase 1 (VRK1) Reveals the C-terminal Tail Essential for Its Structural Stability and Autocatalytic Activity
17. Molecular dynamics simulation study of valyl-tRNA synthetase with its pre- and post-transfer editing substrates
18. Azaindole Based Potentiator of Antibiotics against Gram-Negative Bacteria
19. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of α-glucosidase inhibitors
20. Molecular dynamics simulation study of PTP1B with allosteric inhibitor and its application in receptor based pharmacophore modeling
21. Steps to (s)-stereoisomers: Rationalization of a standard Short-chain dehydrogenase for the reduction of multiple pharmaceutical ketone intermediates
22. In vitro anti-diabetic activity, bioactive constituents, and molecular modeling studies with sulfonylurea receptor1 for insulin secretagogue activity of seed extract of Syzygium cumini (L.)
23. Pharmacophore modeling for protein tyrosine phosphatase 1B inhibitors
24. Pharmacophore identification and virtual screening for methionyl-tRNA synthetase inhibitors
25. Combating Multidrug‐Resistant Bacteria by Integrating a Novel Target Site Penetration and Receptor Binding Assay Platform Into Translational Modeling
26. Mechanistic insights into non-immunosuppressive immunophilin ligands as potential antimalarial therapeutics
27. Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer
28. NMR and crystallographic structures of the FK506 binding domain of human malarial parasite Plasmodium vivax FKBP35
29. Crystallographic structure of the tetratricopeptide repeat domain of Plasmodium falciparum FKBP35 and its molecular interaction with Hsp90 C-terminal pentapeptide
30. Correction: Suprafenacine, an Indazole-Hydrazide Agent, Targets Cancer Cells Through Microtubule Destabilization
31. Nitrothiophene carboxamides, a novel narrow spectrum antibacterial series: Mechanism of action and Efficacy
32. Delineating Substrate Diversity of Disparate Short-Chain Dehydrogenase Reductase from Debaryomyces hansenii
33. Suprafenacine, an Indazole-Hydrazide Agent, Targets Cancer Cells Through Microtubule Destabilization
34. Ligand Binding Mode Prediction by Docking: Mdm2/Mdmx Inhibitors as a Case Study
35. The Natively Disordered Loop of Bcl-2 Undergoes Phosphorylation-Dependent Conformational Change and Interacts with Pin1
36. Corrigendum to “Analysis of the Active-Site Mechanism of Tyrosyl-DNA Phosphodiesterase I: A Member of the Phospholipase D Superfamily” [J. Mol. Biol. 415/4 (2012) 741–758]
37. Molecular Basis of Bcl-XL-p53 Interaction: Insights from Molecular Dynamics Simulations
38. Mechanistic insights into non-immunosuppressive immunophilin ligands as potential antimalarial therapeutics
39. SRF, a novel anti‐cancer drug, inhibits microtubule polymerization and dynamics and induces hyperphosphorylation of Bcl‐2 in cancer cells
40. Molecular Docking Study of Aminoacyl-tRNA Synthetases with Ligand Molecules from Four Different Scaffolds
41. Crystallographic structure of the tetratricopeptide repeat domain ofPlasmodium falciparumFKBP35 and its molecular interaction with Hsp90 C-terminal pentapeptide
42. Urokinase Inhibitor Design Based on Pharmacophore Model Derived from Diverse Classes of Inhibitors
43. LigandBinding Mode Prediction by Docking: Mdm2/MdmxInhibitors as a Case Study.
44. Mechanistic insights into non-immunosuppressive immunophilin ligands as potential antimalarial therapeutics.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.